Brian Lockhart
Global Head of Companion Diagnostics Servier
Seminars
Tuesday 23rd September 2025
Around the CDx World in 80 Days: Navigating Companion Diagnostics Challenges from US to Japan to China to EU
11:50 am
- Presenting recent case-studies on CDx filings/approvals in US, Japan, China and EU territories from the Pharma perspective
- Highlighting issues to anticipate and challenges to expect and learn to expect the unexpected
- Working with accelerated approvals timelines
- The importance of ‘Local’ knowledge
- Terra incognita … IVD filings beyond the Big 4
Thursday 25th September 2025
Panel Discussion: Paving Towards Strategic Drug-Diagnostic Market Entry in China – From Trial Design to Commercial Success
9:00 am
- Which potential challenges in trial design are we aware of?
- Which CDx strategy and testing models are optimal for maximizing market patient access in China?
- What are the CDx policies and regulations across China, and how can we address critical bottlenecks regarding regulatory adherence and commercialization?
- What precision medicine marker developments are currently underway which might change the future testing paradigm? How might this inform vendor selection?
